StockDrifts LogoStockDrifts

Blue Owl Capital Holdings 13F Portfolio

Portfolio Manager
Blue Owl Capital Holdings LP
Performance
+6.82% (2026 Q2)
AUM (13F)
$664.51M
# of Holdings
71
Performance Rank
Allocation (Top 20)
55.21%
Latest filing
Q2 2026

Blue Owl Capital Holdings LP Holdings Map

Top 50 Blue Owl Capital Holdings LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
AKTS
AKTIS ONCOLOGY INC
15.04%3.07M$99.0M
-2.88%(-91.13K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 3.16M shares2026-Q2: 3.07M shares
$17.89(+39.35%)
2026-06-30
CGEM
CULLINAN THERAPEUTICS INC
4.26%1.54M$28.0M
-19.37%(-370.00K)
2025-Q2: 2.39M shares2025-Q3: 2.51M shares2025-Q4: 2.35M shares2026-Q1: 1.91M shares2026-Q2: 1.54M shares
$10.16(+100.15%)
2026-06-30
LRMR
LARIMAR THERAPEUTICS INC
4.25%9.16M$27.9M
+28.70%(+2.04M)
2025-Q2: 4.93M shares2025-Q3: 5.85M shares2025-Q4: 6.82M shares2026-Q1: 7.12M shares2026-Q2: 9.16M shares
$4.18(+4.29%)
2026-06-30
NCDL
NUVEEN CHURCHILL DIRECT LEND
4.05%2.14M$26.6M
+0.00%(+0)
2025-Q2: 4.04M shares2025-Q3: 3.09M shares2025-Q4: 2.14M shares2026-Q1: 2.14M shares2026-Q2: 2.14M shares
$17.41(-28.55%)
2026-06-30
MPLT
MAPLIGHT THERAPEUTICS INC
3.98%729.9K$26.2M
-27.44%(-276.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 327.1K shares2026-Q1: 1.01M shares2026-Q2: 729.9K shares
$18.50(-36.48%)
2026-06-30
COF
CAPITAL ONE FINL CORP
3.65%119.8K$24.0Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 119.8K shares
$189.38(+16.94%)
2026-06-30
OBDC
BLUE OWL CAPITAL CORPORATION
3.38%2.05M$22.2M
+0.00%(+0)
2025-Q2: 2.05M shares2025-Q3: 2.05M shares2025-Q4: 2.05M shares2026-Q1: 2.05M shares2026-Q2: 2.05M shares
$11.91(-2.43%)
2026-06-30
DELL
DELL TECHNOLOGIES INC
2.16%33.0K$14.2M
+137.15%(+19.06K)
2025-Q2: 20.8K shares2025-Q3: 52.3K shares2025-Q4: 53.8K shares2026-Q1: 13.9K shares2026-Q2: 33.0K shares
$216.26(+121.94%)
2026-06-30
HLLY
HOLLEY INC
1.7%4.38M$11.2M
+3.30%(+140.00K)
2025-Q2: 4.11M shares2025-Q3: 4.86M shares2025-Q4: 4.15M shares2026-Q1: 4.24M shares2026-Q2: 4.38M shares
$2.97(+4.68%)
2026-06-30
EYPT
EYEPOINT INC
1.66%762.6K$10.9M
-16.44%(-150.00K)
2025-Q2: 562.6K shares2025-Q3: 367.6K shares2025-Q4: 392.6K shares2026-Q1: 912.6K shares2026-Q2: 762.6K shares
$12.35(+19.45%)
2026-06-30

About Blue Owl Capital Holdings LPโ€™s portfolio

Blue Owl Capital Holdings LP reports $664.51M in US-listed equity holdings across 71 positions in its most recent 13F filing. Its largest disclosed positions are AKTS (15.0%), CGEM (4.3%) and LRMR (4.3%). The top 20 holdings account for 55.21% of reported assets. Its disclosed equity book has returned +16.88% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
AKTS โ€” 24.6% ($98.95M)CGEM โ€” 7.0% ($28.04M)LRMR โ€” 6.9% ($27.95M)NCDL โ€” 6.6% ($26.62M)MPLT โ€” 6.5% ($26.16M)COF โ€” 6.0% ($24.03M)OBDC โ€” 5.5% ($22.23M)DELL โ€” 3.5% ($14.22M)HLLY โ€” 2.8% ($11.16M)EYPT โ€” 2.7% ($10.91M)Other โ€” 28.0% ($112.75M)
72%in top 10
  • AKTS24.6%
  • CGEM7.0%
  • LRMR6.9%
  • NCDL6.6%
  • MPLT6.5%
  • COF6.0%
  • OBDC5.5%
  • DELL3.5%
  • HLLY2.8%
  • EYPT2.7%
  • Other28.0%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
11
COFCAPITAL ONE FINL CORP3.6%
ARTVARTIVA BIOTHERAPEUTICS INC1.3%
CMPSCOMPASS PATHWAYS PLC1.0%
VRDNVIRIDIAN THERAPEUTICS INC0.7%
+7 opened
Added to
11
DELLDELL TECHNOLOGIES INC+137.1%
SGMTSAGIMET BIOSCIENCES INC+277.5%
LRMRLARIMAR THERAPEUTICS INC+28.7%
ORICORIC PHARMACEUTICALS INC+166.7%
+7 more
Trimmed
11
MPLTMAPLIGHT THERAPEUTICS INC-27.4%
CGEMCULLINAN THERAPEUTICS INC-19.4%
RAREULTRAGENYX PHARMACEUTICAL IN-39.7%
ELDNELEDON PHARMACEUTICALS INC-60.1%
+7 more

Unlock alerts, watchlists & AI chat

Sign up free to track Blue Owl Capital Holdings LP, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Blue Owl Capital Holdings LPโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1858703). View Blue Owl Capital Holdings LPโ€™s 13F filings on SEC

More 13F analyses

View all